Indication: Parkinson's Disease
Type of Study: Patient registry
Sponsor: U.S. pharmaceutical Company
Patient Population: 5,000
Investigative Sites: 500
ViewPoint FUSE Team partnered with a pharmaceutical company and industry leading CRO to design and develop an EDC platform for a Parkinson's disease registry. This study was 6 months in duration, enrolling 500 sites and 5000 patients in the Pre-Product Launch phase with a Post-Launch phase upon commercial launch of the study drug. This study had 4 different workflows including a call center workflow for the CRO to collect outbound call surveys from patients.
Indication: Multiple Sclerosis
Type of Study: Longitudinal observational patient registry
Sponsor: Biotechnology Company and CRO
Patient Population: 500
Investigative Sites: 50
The ViewPoint FUSE Team developed an on-line EDC solution for a biotechnology company and CRO in support of a longitudinal study conducted at approximately 50 sites throughout Canada and enrolled approximately 500 adult patients diagnosed with multiple sclerosis and neuropathic pain. This was an observational study involving patients with multiple sclerosis who have a stable pain medication regimen. Data was collected directly from patients and health care providers via electronic patient questionnaires. Patients were followed for a period of 7 months. Real-time project management and clinical benchmark reports were available on-line to track study progress, data cleanliness and patient outcomes. The solution allowed for data collection during regular study visits, as well as daily dataset availability for statistical analysis. A training website was provided to the sites for the practice of entering dummy data without affecting the integrity of the study database.
Indication: Multiple Sclerosis
Type of Study:Randomized, open-label parallel design study
Sponsor: Pharmaceutical company
Patient Population: 1600
Investigative Sites: 100
The ViewPoint FUSE Team developed an on-line evaluation and EDC solution for a biotechnology company and CRO in support of a longitudinal study conducted at approximately 25 sites throughout Canada and enrolled approximately 500 adult patients diagnosed with multiple sclerosis and neuropathic pain. This was an observational study involving patients with multiple sclerosis who have a stable pain medication regimen. Data was collected directly from patients and health care providers via electronic patient questionnaires. Patients were followed for a period of 7 months. Real-time project management and clinical benchmark reports were available on-line to track study progress, data cleanliness and patient outcomes. The solution allowed for data collection during regular study visits, as well as daily dataset availability for statistical analysis. A training website was provided to the sites for the practice of entering dummy data without affecting the integrity of the study database.
